Cimicifuga Racemosa

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Cimicifuga Racemosa
Generic name: CIMICIFUGA RACEMOSA
Manufacturer: OHM PHARMA INC.
Product type: HUMAN OTC DRUG
SPL set ID: 46a7bfa2-50a8-41c4-9d64-2d6fd7e60465
SPL ID: d45e62d3-b51d-530d-e053-2a95a90ac447
Version: 3
Effective date: 2021-12-30
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:13:46

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Cimicifuga Racemosa	openfda.brand_name
generic name		CIMICIFUGA RACEMOSA	openfda.generic_name
manufacturer name		OHM PHARMA INC.	openfda.manufacturer_name
ndc	package	66096-818-01	openfda.package_ndc
ndc	product	66096-818	openfda.product_ndc
ndc11	package	66096081801	derived:openfda.package_ndc
spl id		d45e62d3-b51d-530d-e053-2a95a90ac447	id
spl set id		46a7bfa2-50a8-41c4-9d64-2d6fd7e60465	set_id
unii		K73E24S6X9	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: Keep out of reach of children. If pregnant or breast-feeding , ask a health care professional before use. Stop use and ask a health care professional if symptoms persist for more than 3 days or worsen. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.